OSE Immunotherapeutics S.A.

OSE.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income€37-€23-€18-€17
Dep. & Amort.€6€3€4€3
Deferred Tax€0-€0-€0-€0
Stock-Based Comp.€0€2€3€4
Change in WC€2-€1-€3€1
Other Non-Cash€3-€1-€3-€0
Operating Cash Flow€48-€20-€18-€10
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases-€47€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.-€0-€0€0-€0
Investing Cash Flow-€47-€1€0-€1
Financing Activities
Debt Repay.-€3€8€11€15
Stock Issued€1€12€0€0
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€1-€6-€1-€1
Financing Cash Flow-€3€13€10€15
Forex Effect€0-€0€0€0
Net Chg. in Cash-€2-€7-€8€4
Supplemental Information
Beg. Cash€19€26€34€29
End Cash€17€19€26€34
Free Cash Flow€48-€20-€19-€10